BI Joins Pharma Frenzy For Cancer-Killing Viruses With $244M Acquisition

With its purchase of ViraTherapeutics, German ' s Boehringer Ingelheim joins a large and growing list of Big Pharma companies investing in viruses that are engineered to seek out and destroy cancer.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news